Patents by Inventor Hillary Whiting

Hillary Whiting has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170070120
    Abstract: A adapter for coupling a cable to a motor in a hygienic environment is provided. The hygienic adapter is non-rotatably coupled to and hygienically seals an opening of the motor housing, the hygienic adapter including a port adapted to receive the power supply cable connector such that the connector and cable are oriented parallel to the longitudinal surface of the housing and the connector is accessible to the electrical leads.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 9, 2017
    Inventors: Kevin Garrison, Mike Conner, Eddie Anderson, Gene Matthews, Hillary Whiting, Devin Deeds
  • Publication number: 20070066532
    Abstract: Compositions and methods for alleviating the symptoms associated with muscle pain in general or muscle wasting are provided. The compositions are based on use of androgens, either alone or in combination with other hormones, including growth hormone.
    Type: Application
    Filed: November 2, 2006
    Publication date: March 22, 2007
    Inventor: Hillary White
  • Publication number: 20060100186
    Abstract: Compositions and methods for alleviating the symptoms associated with chronic fatigue syndrome and fibromyalgia syndrome are provided. The compositions are based on use of a transdermal gel formulation delivery system for androgens, either alone or in combination with other hormones.
    Type: Application
    Filed: December 16, 2005
    Publication date: May 11, 2006
    Inventors: Hillary White, Robert Gyurik
  • Publication number: 20060058217
    Abstract: Compositions and methods for treatment of ovarian cancer are described. The compositions comprise antalamin, a compound that increases cytotoxic T-cell lytic activity at tumor sites. Methods of treatment for ovarian cancer are based on the administration of antalarmin to increase cytotoxic T-cell lytic activity or anti-tumor activity, which leads to killing of tumor cells by cytotoxic T cells.
    Type: Application
    Filed: January 20, 2004
    Publication date: March 16, 2006
    Inventors: Hillary White, Katherine Terranova